Latest filing published 14 Aug 2026 for Amneal Pharmaceuticals, Inc., €765k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
John Kiely, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Amneal Pharmaceuticals, Inc. and Zovio Inc. The record holds 19 filings, for trades running from 19 May 2020 to 13 August 2026.
Market trades split into 2 purchases (€76k) and 4 sales (€1.5M). The net balance comes to €1.4M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 12 option exercises. 2026 to date brings no purchases and 1 sale.
The newest entry dates from 14 August 2026: a transaction, in Amneal Pharmaceuticals, Inc. The last insider purchase was made public on 10 September 2020, 2,235 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations